Position in IMCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$145,598,992
-$11,957,507 QoQ
Shares Held
4,829,154
+6.4% QoQ
Ownership
9.49%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99.89377021316777.ToString("F0")%
Shared 0.ToString("F0")%
None 0.10622978683222777.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. IMCR ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $145,598,992 | 4,829,154 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $157,556,499 | 4,539,225 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $160,593,239 | 4,420,403 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $152,374,123 | 4,855,772 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $143,617,514 | 4,840,496 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $142,122,119 | 4,817,699 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $150,545,924 | 4,836,040 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $163,099,148 | 4,812,604 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $280,289,360 | 4,312,144 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $115,897,090 | 1,696,386 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $110,869,972 | 2,136,223 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $122,684,574 | 2,046,107 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $103,307,400 | 2,089,551 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $114,363,314 | 2,003,913 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $65,398,403 | 1,393,234 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $50,755,926 | 1,360,384 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $48,663,893 | 1,627,555 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $72,702,714 | 2,123,327 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $80,849,149 | 2,180,986 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $48,103,507 | 1,231,844 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $60,497,801 | 1,421,137 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||